Thus, SNPs in the TERT, RTEL1 and CDKN2B regions were strongly associated with high-grade glioma risk. While chromosomal imbalances and aberrant mRNA and miRNA expression profiles can be identified in tumor cells after tumor formation, putative SNPs that might be associated with an increased risk for developing glioblastoma can be identified prior to tumor formation in DNA from normal samples of a patient. The gene discussed is CDKN2B; the disease is neoplasm.